Clinical Trials Logo

Asthma, Exercise-Induced clinical trials

View clinical trials related to Asthma, Exercise-Induced.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03327701 Not yet recruiting - Clinical trials for Asthma, Exercise-Induced

The Effect of Benralizumab on Exercise-induced Bronchoconstriction

Start date: December 2017
Phase: Phase 3
Study type: Interventional

Severe asthma affects 5-10% of more than 300 million asthmatics. Ten to twenty percent of individuals suffering from asthma do not respond well to current treatment due to the complexity of the different mechanisms underlying asthma pathogenesis, and sometimes due to an insufficient effect of treatment on underlying airway inflammation. Consequently, some asthmatics have poorer quality of life due to: frequent asthma symptoms, regular medical or emergency visits, limitation in their activities of daily living, including exercise. It is believed that the benralizumab can help to reduce airway inflammation and thus improve exercise tolerance in individuals with asthma. The main objective of this study is to determine the effect of benralizumab on exercise-induced bronchoconstriction (EIB) and exercise tolerance in moderate to severe eosinophilic asthmatics, in comparison with baseline values and a placebo treatment.